| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.71▼ | 1.70▼ | 1.71▼ | 1.71▼ | 1.72▼ |
| MA10 | 1.71▼ | 1.72▼ | 1.73▼ | 1.73▼ | 1.65▲ |
| MA20 | 1.71▼ | 1.73▼ | 1.74▼ | 1.72▼ | 1.86▼ |
| MA50 | 1.72▼ | 1.74▼ | 1.73▼ | 1.66▲ | 1.93▼ |
| MA100 | 1.73▼ | 1.73▼ | 1.76▼ | 1.91▼ | 3.97▼ |
| MA200 | 1.74▼ | 1.76▼ | 1.70▼ | 1.97▼ | 8.84▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.004▼ | -0.005▼ | -0.005▼ | 0.001▲ |
| RSI | 40.622▼ | 35.851▼ | 39.245▼ | 47.634▼ | 43.755▼ |
| STOCH | 73.611 | 11.569▼ | 15.842▼ | 25.036 | 33.534 |
| WILL %R | -75.000▼ | -94.118▼ | -94.118▼ | -87.179▼ | -82.731▼ |
| CCI | -33.333 | -92.478 | -140.938▼ | -56.266 | -22.510 |
|
Tuesday, March 10, 2026 11:21 AM
Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO) and ...
|
|
Thursday, March 05, 2026 01:36 PM
INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious diseases, ...
|
|
Thursday, March 05, 2026 10:21 AM
Robbins LLP reminds stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/03/26 | 1.73 | 1.78 | 1.69 | 1.69 | 1,083,707 |
| 10/03/26 | 1.72 | 1.77 | 1.72 | 1.73 | 560,442 |
| 09/03/26 | 1.74 | 1.775 | 1.72 | 1.73 | 772,387 |
| 06/03/26 | 1.71 | 1.77 | 1.685 | 1.74 | 581,964 |
| 05/03/26 | 1.75 | 1.75 | 1.65 | 1.68 | 759,500 |
| 04/03/26 | 1.71 | 1.7987 | 1.71 | 1.73 | 683,865 |
| 03/03/26 | 1.73 | 1.74 | 1.68 | 1.68 | 577,163 |
| 02/03/26 | 1.76 | 1.77 | 1.69 | 1.74 | 591,529 |
| 27/02/26 | 1.79 | 1.82 | 1.76 | 1.81 | 351,500 |
| 26/02/26 | 1.83 | 1.83 | 1.76 | 1.79 | 449,000 |
|
|
||||
|
|
||||
|
|